Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT04195100Phase 1Completed
Phase 1, randomised trial of pilocarpine in xerostomia (2 arms), sponsored by Maastricht University Medical Center+. Primary endpoints: Change in xerostomia score (Numeric Rating Scale) at 3 weeks and Change in oral health-related quality of life (Dutch Geriatric Oral Health Assessment Index) at 2 weeks. Started Apr 2019; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT04195100.